The Fate of 2,4,6-Tri-(3',5'-di-tert.-butyl-4'-hydroxybenzyl)mesitylene (lonox 330) attack (Rocklin & Van Winkle, 1962 water were supplied, and the urine and faeces were collected 3eparately at daily intervals.
The man was a 29-year-old volunteer (80kg. body wt.). At the beginning of the experiment, a gelatin capsule containing 104-4mg. (1.25mg./kg.) of lonox 330 was taken Drally. The human subject had a normal diet, and the urine and faeces were collected separately.
Female pigs (approx. 8 weeks old; 21kg. body wt.) were used (Large White strain, maintained as a closed colony on the College farm, University College ofNorth Wales, Bangor, Caernarvonshire). After being weaned, the pigs were fed on a standard diet, which consisted of a mixture of barley (66 parts by wt.), fish meal (8 parts by wt.) and soya-bean meal (5 parts by wt.) together with mineral-salt and vitamin additives. The bile duct was cannulated and bile drained to the outside, the animals were fed on a mixed diet, and fresh bile equivalent to that secreted was administered daily by stomach tube (Rous & McMaster, 1923 water and drying at 1200. This alumina was reactivated at 6000, and by homogeneous addition of moisture its activity was decreased to activity III (Brockmann & Schodder, 1941) . Individual lipid components were successively eluted from alumina columns (Reichstein & Shoppee, 1949) lonox 330 could be isolated quantitatively by direct column chromatography of the total lipid fraction from faeces, since it was eluted after ,Bcarotene and the sterol esters and before the triglyceride and cholesterol fractions (Table 2) . This separation was tedious, and a more rapid procedure was devised that facilitated separation by prior concentration of the unsaponifiable lipids. The chromatographic separation of Ionox 330 from the unsaponifiable lipid fraction of the 3-day faeces of a man who had been treated with the antioxidant is exemplified in Table 3 . Ionox 330 is eluted after fl-carotene and before skatole, cholesta-3,5-dien-7-one and cholesterol.
The usual methods employed for the estimation of phenols in biological material (Bray & Thorpe, 1954; Hathway, 1960 ) cannot be used for 2,5-ditert.-butylphenols because of the sterically hindered hydroxyl group. Although Ionox 330 reacts with ferric chloride-2,2'-bipyridyl (Anglin, Mahon & Chapman, 1956 ), in our hands this method was not sufficiently accurate nor applicable to the routine analysis of the compound in samples of faeces. For Table 2 . Separation of lonox 330 from the ether-soluble constituents of rat faeces by adsorption chromatography on alumina One-fifth of the ether-soluble fraction from the faeces of a rat that had been treated orally with Ionox 330 (106-6mg.) was chromatographed on an alumina column (20mm. diam. x 15 cm. long). Total recovery was 1-12g. from an ether-soluble fraction weighing 3-0g. In this experiment, the presence of such a high proportion of cholesterol esters, phospholipids and triglycerides among these ether-soluble constituents was due to some contamination of the faeces by food, and the low recovery was caused by retention of phospholipid and hydrolysis of triglyceride on the column (Wright, 1959 by column chromatography and estimated in appropriate fractions either by measurement of radioactivity or by ultraviolet spectroscopy. Confirmation of a free unconjugated hydroxyl group was obtained from measurements of the infraredabsorption spectra of the antioxidant and the faecal product (cf. Bohn & Campbell, 1957) . No metabolites of Ionox 330 were detected by measurement of radioactivity in any of the fractions separated from either faeces or tissues, nor were they detected in the corresponding chromatograms either by the sensitive antimony pentachloride location reagent or by radioautography.
In an initial experiment with a dozen adult male rats that had been treated orally with [14C]Ionox 330, unchanged Ionox 330 was recovered quantitatively from the faeces (Table 4) . Virtually no 14C was measured in the urine and expired gases of the same animals. The very low concentrations of 14C that were measured in the combined carcasses and remaining viscera after removal of the alimentary canal ofthese animals (Table 4) 72hr. after dosage are ascribed to slight contamination of the fur, which was not removed in this experiment. A small degree of contamination of the fur is bound to occur in all metabolic experiments with rodents. Rats did not show a sex difference in the pattern of elimination (Table 5) .
When Ionox 330 was administered to adult male rats that had been fitted with collars to prevent coprophagy, three-quarters or more of an oral dose of the antioxidant was eliminated in 24hr. and the remainder during 24-48hr. after dosage (Table 6) . Very little was eliminated after 48hr. (Brodie, 1964) , but the absolute solubility at the pH of the gut contents is also important. For example, dicoumarol has a high lipid/water partition coefficient and is rapidly absorbed from solution, but it is precipitated in the gut, and the dissolution of the crystalline state is the limiting factor in the absorption process. Precipitation also influences the absorption of some phenylbutazone analogues. Ionox 330 is precipitated from lipid solution in the gut as the lipid is absorbed. Cholesterol is precipitated from lipid solution in the gut, and is absorbed by replacement of cholesterol in mucosal cells by more cholesterol from the external side (Ganguly, Krishnamurthy & Mahadevan, 1959; Glover & Green, 1959; Murthy, David & Ganguly, 1963) . Because of its shape and size, Ionox 330 is unlikely to displace another substance that may be present among the lipoproteins of the cell membrane, and thereby penetrate the cell. If a carrier protein is involved in cholesterol absorption (Desai & Glover, 1961) , then this protein that has affinity for 3,-sterols would not be expected to interact with the essentially different Ionox 330 molecule, which has hindered hydroxyl groups. It may be noted that liquid paraffin (Cl6H34-C24H50) is absorbed to a limited extent from the gut (Alvarez, 1947; Stryker, 1941) .
Ionox 330 is not metabolized by animals because of its non-absorption and because of its stability to the soluble enzymes of the alimentary canal and intestinal flora. It contrasts in this respect with the related antioxidant, 2,6-di-tert.-butyl-p-cresol (Ionol) , which is transformed into a glucuronide and a glycine conjugate of 3,5-di-tert.-butyl-4-hydroxybenzoic acid, fl-(3-tert.-butyl-2-hydroxy-5-methylphenyl)-pfl-dimethylethyl ,B-D-glucosiduronic acid, and ethereal sulphate (Dacre, 1961) , presumably in the liver. These metabolites account for 54-1% (±7.2%) of the dose given to rabbits, and Dacre (1961) says that the fate of the remainder is unknown.
